Skip to main content
Clinical Trials/JPRN-UMIN000015727
JPRN-UMIN000015727
Completed
未知

Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter study - - Randomized, controlled trial of ipragliflozin and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.

Saga University0 sites55 target enrollmentNovember 24, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
type 2 diabetic patients with NAFLD/NASH
Sponsor
Saga University
Enrollment
55
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2014
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Ppatients with diabetes 2\.Patients with past history of ovascular lesion or stroke 3\.Patients with past history of allergy 4\.Patients with the necessity of IRI therapy 5\.Patients with past history of liver disorder or renal dysfunction 6\.Inadequacy of usingig this therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials